USPTO serial 79311070
M MENARINI PILLS OF QUALITY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 25, 2022
- Examiner
- HOPKINS, SARAH COLLEEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with M MENARINI PILLS OF QUALITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Arthur DeBaugh
Arthur DeBaugh Allman Spry Leggett Crumpler & Horn, P.A.380 Knollwood Street, Suite 700Winston-Salem, NC 27103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibiotics; anti-cancer preparations; diagnostic reagents for use in medical clinics; diagnostic test reagents for medical use for testing body fluids for microorganisms; diagnostic kits composed of diagnostic agents, preparations and substances for medical use in disease testing; pharmaceutical preparations for the treatment of inflammatory disorders; medicated skin care preparations for skin treatment; pharmaceutical preparations for treating skin disorders | ACTIVE | — |
| 009 | Blank magnetic data carriers, recording discs; DVDs featuring information on pharmacovigilance and quality control for pharmaceutical products; blank compact discs; digital recording media, namely, pre-recorded video cassettes, digital video discs, digital versatile discs, downloadable audio and video recordings, DVDs, and high definition digital discs featuring information on pharmacovigilance and quality control for pharmaceutical products; downloadable computer software for editing cinematographic film and for creating videos; apparatus for editing cinematographic film; electronic downloadable publications, namely, newsletters and magazines in the field of pharmaceutical drugs and medicine; camcorders; photographic cameras; cinematographic films featuring information on pharmacovigilance and quality control for pharmaceutical products; musical sound recordings; musical video recordings; blank USB flash drives; downloadable mobile software applications for facilitating pharmaceutical products quality control and pharmacovigilance; sound transmitting apparatus; apparatus for transmitting images; apparatus for reproducing images; sound reproduction apparatus; apparatus for recording images; sound recording apparatus | ACTIVE | — |
| 016 | Paper; paper stationery; printed materials, namely, books, magazines, printed matter in the nature of articles, catalogues, printed publications in the nature of pamphlets in the field of pharmaceutical drugs and medicine; stationery; writing stationery; cardboard boxes; conical paper bags; printed postcards; printed advertising posters; printed mounted posters; printed photographs; placards of paper; placards of cardboard; paper signboards; printed calendars; printed almanacs; copyholders; paperweights; pencil cups; pencil holders; document portfolios; pens; writing or drawing books; printed diaries | ACTIVE | — |
| 041 | Education services, namely, arranging of seminars, lectures and conventions in the fields of pharmaceutical products quality control and pharmacovigilance; arranging of displays for cultural purposes in the field of pharmaceutical products quality control and pharmacovigilance; art exhibition services; organising events in the field of pharmaceutical products quality control and pharmacovigilance for cultural purposes; organisation of cultural, entertainment, and sporting events, namely, events in the fields of pharmaceutical products quality control and pharmacovigilance for cultural or educational purposes; conducting guided tours of cultural sites for educational purposes; digital video, audio, and multimedia publishing services; organisation of cultural activities in the nature of festivals and art exhibitions in the field of medicine; production of radio and television entertainment services; audio recording and video production, and photography; production of television programs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 041
- Similar marks named M MENARINI PILLS OF QUALITY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 31, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 31, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 12, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 12, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 16, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 13, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jul 13, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 25, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 26, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 7, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 7, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 6, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 29, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 29, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 29, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 29, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 25, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 7, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 7, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 27, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 26, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2021 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Aug 7, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 6, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 17, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 17, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 14, 2021 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |